Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-infectious irritable bowel syndrome.

Robin Spiller1, Eugene Campbell

  • 1Wolfson Digestive Diseases Centre, University Hospital, Nottingham, UK. Robin.Spiller@nottingham.ac.uk

Current Opinion in Gastroenterology
|December 2, 2005
PubMed
Summary

Low-grade inflammation in the gut is a key factor in post-infectious irritable bowel syndrome (IBS). Research shows increased inflammatory cells and cytokines, suggesting probiotics may help manage IBS symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Normalization of Gastrointestinal Symptoms in Adults With Constipation With Daily Green Kiwifruit Consumption: Protocol for an Open-Label Intervention Study.

JMIR research protocols·2026
Same author

Clinical Characteristics and Outcomes of Rome IV Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea Prescribed With Ondansetron: A Real-World Study.

Neurogastroenterology and motility·2025
Same author

Assessing Water Content of the Human Colonic Chyme Using the MRI Parameter T1: A Key Biomarker of Colonic Function.

Neurogastroenterology and motility·2025
Same author

Magnetic Resonance Imaging Reveals Novel Insights into the Dual Mode of Action of Bisacodyl: A Randomized, Placebo-controlled Trial in Constipation.

Clinical pharmacology and therapeutics·2024
Same author

Editorial: Emulsifiers and thickeners in our food-Do they alter gut permeability?

Alimentary pharmacology & therapeutics·2024
Same author

A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study.

NIHR open research·2024

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiology

Background:

  • Irritable bowel syndrome (IBS) is a heterogeneous disorder with both central and peripheral components.
  • The peripheral component is particularly significant in post-infectious IBS (PI-IBS).

Purpose of the Study:

  • To review recent findings on the pathophysiology of PI-IBS.
  • To explore novel therapeutic approaches for IBS based on inflammatory pathways.

Main Methods:

  • Review of recent scientific literature on PI-IBS.
  • Analysis of studies investigating gut mucosal abnormalities, permeability, and inflammatory markers in IBS patients.
  • Evaluation of treatment outcomes for steroid and probiotic therapies.

Main Results:

Related Experiment Videos

  • Contrary to previous beliefs, IBS is associated with low-grade inflammation, including lymphocytic infiltration, increased gut permeability, and elevated enterochromaffin and mast cells.
  • Increased levels of inflammatory cytokines have been observed in both the gut mucosa and blood of IBS patients.
  • Steroid treatments have shown limited efficacy, whereas preliminary studies indicate potential benefits from anti-inflammatory probiotics.

Conclusions:

  • The study of PI-IBS highlights the critical role of low-grade inflammation in symptom development.
  • Novel therapeutic strategies for IBS may involve targeting serotonin and histamine metabolism, potentially benefiting various IBS subtypes.